WTO TRIPS Council Looks At IP And The Public Interest, Importance Of Research Exemption 28/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment A relatively new topic of discussion at the World Trade Organization committee on intellectual property is the relationship between intellectual property and the public interest. This week, WTO delegates discussed the application and benefits of a regulatory exception to IP rights allowing earlier entry of generics to the market, known as the Bolar exception. The committee also heard about a request from least-developed countries (LDCs) to improve technology transfer measures that developed countries have the obligation to provide under WTO rules.
Academies’ Group Urges EU Harmonisation Of Rules On Inventorship, Patenting 28/02/2018 by Intellectual Property Watch Leave a Comment A high-level group of academic experts in intellectual property rights and innovation in the European Union has released a statement highlighting the rise in inventions due to international research and development and says EU regulations on inventorship, assignment and patent filing should be assessed for harmonisation and reducing complexity.
WTO TRIPS Council: For Some, IP-Intensive Industries Are Engine Of Economy. For Others, IP Alone Is Not Sufficient 28/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Trade Organization committee on intellectual property met this week and gave an opportunity to WTO members to discuss the value of intellectual property for micro, small and medium sized enterprises (MSMEs), and its importance for IP-intensive industries. Several members, such as the European Union on behalf of its members presented data to illustrate the importance of IP for MSMEs. Meanwhile, India and South Africa remarked that IP is only one factor to promote innovation, but are not a sufficient ingredient.
Section 1201 Rulemaking – The Process Is Moving Along 28/02/2018 by Intellectual Property Watch Leave a Comment Dave Davis writes: Section 1201 is a curious little section of the US Copyright Act, added by the Digital Millennium Copyright Act (DMCA) of 1998. But the matter covered in that section is of great importance in our digital age and, due to its triennial rulemaking requirement, ‘1201’ exceptions are a topic of considerable discussion every few years. As it turns out, 2018 is one of those years.
Authors’ Group Study: Copyright Safe Harbour Provisions Distort Market 28/02/2018 by Intellectual Property Watch 1 Comment Copyright “safe harbour” rules aimed at ensuring the free flow of information by internet service providers without liability for infringing content are “distorting the digital market, profiting tech giants and leading to significant underpayment of copyright owners,” according to an international authors’ industry association study released this week.
WTO, WHO, WIPO Heads Share Views On Innovation And Access At Trilateral Symposium 27/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment How to encourage health innovations and make sure that new medicines, vaccines, or diagnostics will reach every person who needs them? That is a question which has been hotly debated in different fora. Yesterday, the World Trade Organization, UN World Health Organization, and UN World Intellectual Property Organization jointly held a symposium on how innovative technologies can promote the United Nations Sustainable Development Goals. The WHO director general called on his colleagues to support policies facilitating access to health technologies.
Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation 27/02/2018 by William New, Intellectual Property Watch Leave a Comment The Wellcome Trust, the London-based biomedical research charity, has issued recommendations for improved scientific collaboration after Brexit, including to establish a formal agreement on research and innovation. This includes continued leadership by the UK on open research, and might include expanding the UK patent box scheme, it says.
German Court To Hear Unified Patent Court Challenge, As EPO Staff Questions Persist 26/02/2018 by Dugie Standeford for Intellectual Property Watch 1 Comment The German Federal Constitutional Court has agreed to take up a challenge that could potentially derail the Unified Patent Court (UPC). The special – and opaque – procedure under the national constitution allows a single individual to claim constitutional breaches, said Hogan Lovells (Dusseldorf) patent litigator Clemens Plassmann. The lawsuit leaves the UPC in disarray at least until next year, he said. Meanwhile, in the never-ending feud between European Patent Office (EPO) management and staff, President Benoȋt Battistelli was forced to back off from a planned rule change that would allow him to fire staff members “if the exigencies of the service require abolition of their post or a reduction in staff.”
Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it.
Least Developed Countries Ask For Better Implementation Of TRIPS Tech Transfer Requirements 23/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Trade Organization council on intellectual property rights will hold the first of its three annual meetings next week. The now-usual item on IP and innovation is joined by a discussion topic on IP and the public interest. Separately, the WTO least developed countries group has put forward a request that developed countries fully implement their technology transfer requirements under the WTO rules. The council meeting will be preceded by a high-level trilateral meeting of the WTO, World Health Organization and World Intellectual Property Organization.